Schmid John P. has filed 33 insider transactions across 4 companies since January 2023.
Most recent transaction: a sale of 522 shares of ANAPTYSBIO, INC ($ANAB) on March 30, 2026.
Activity breakdown: 6 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | S | Common Stock | 522 | $57.40 | 31,622.0000 | 27,688,470 | 1.62% | 0.00% |
| March 30, 2026 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | S | Common Stock | 7527 | $56.70 | 32,144.0000 | 27,688,470 | 18.97% | 0.03% |
| March 30, 2026 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | S | Common Stock | 12596 | $55.71 | 39,671.0000 | 27,688,470 | 24.10% | 0.05% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | A | Stock Option (right to buy) | 5500 | $0.00 | 5,500.0000 | 27,688,470 | 9999.99% | 0.02% |
| Jan. 6, 2026 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | A | Restricted Stock Unit | 4000 | $0.00 | 4,000.0000 | 27,688,470 | 9999.99% | 0.01% |
| Dec. 23, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | J | Common Stock | 11068 | $51.00 | 52,267.0000 | 27,688,470 | 17.48% | 0.04% |
| Aug. 11, 2025 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Schmid John P. | Other | M | Class B ordinary shares | 30000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 11, 2025 | BridgeBio Oncology Therapeutics, Inc. | $BBOT | Schmid John P. | Other | M | Common Stock | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | M | Common Stock | 6030 | $0.00 | 63,335.0000 | 30,666,781 | 10.52% | 0.02% |
| June 15, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | M | Restricted Stock Unit | 6030 | $0.00 | 0.0000 | 30,666,781 | 100.00% | 0.02% |
| June 10, 2025 | Design Therapeutics, Inc. | $DSGN | Schmid John P. | Not found | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 56,762,678 | 9999.99% | 0.03% |
| March 25, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | J | Common Stock | 11068 | $18.18 | 57,305.0000 | 30,666,781 | 23.94% | 0.04% |
| Jan. 13, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | M | Stock Option (right to buy) | 21692 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 13, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | M | Stock Option (right to buy) | 20645 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 13, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | M | Common Stock | 21692 | $4.55 | 25,592.0000 | 0 | 556.21% | 0.00% |
| Jan. 13, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | M | Common Stock | 20645 | $8.54 | 46,237.0000 | 0 | 80.67% | 0.00% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | A | Stock Option (right to buy) | 16510 | $0.00 | 16,510.0000 | 0 | 9999.99% | 0.00% |
| Jan. 7, 2025 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | A | Restricted Stock Unit | 6030 | $0.00 | 6,030.0000 | 0 | 9999.99% | 0.00% |
| Aug. 12, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Schmid John P. | Director | P | Common Stock | 4515 | $2.25 | 138,359.0000 | 137,674,857 | 3.37% | 0.00% |
| Aug. 9, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Schmid John P. | Director | P | Common Stock | 4285 | $2.37 | 133,844.0000 | 137,674,857 | 3.31% | 0.00% |
| June 15, 2024 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | M | Common Stock | 3900 | $0.00 | 3,900.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2024 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Not found | M | Restricted Stock Unit | 3900 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 13, 2024 | Design Therapeutics, Inc. | $DSGN | Schmid John P. | Not found | A | Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 0 | 9999.99% | 0.00% |
| June 5, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Schmid John P. | Director | A | Common Stock | 50000 | $0.00 | 129,559.0000 | 137,674,857 | 62.85% | 0.04% |
| May 10, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Schmid John P. | Director | P | Common Stock | 5400 | $1.91 | 79,559.0000 | 137,674,857 | 7.28% | 0.00% |
| March 22, 2024 | Design Therapeutics, Inc. | $DSGN | Schmid John P. | Not found | P | Common Stock | 9156 | $3.62 | 39,830.0000 | 0 | 29.85% | 0.00% |
| March 25, 2024 | Design Therapeutics, Inc. | $DSGN | Schmid John P. | Not found | P | Common Stock | 17809 | $3.74 | 57,639.0000 | 0 | 44.71% | 0.00% |
| March 14, 2024 | Xeris Biopharma Holdings, Inc. | $XERS | Schmid John P. | Director | P | Common Stock | 4500 | $2.16 | 74,159.0000 | 137,674,857 | 6.46% | 0.00% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Director | A | Restricted Stock Unit | 6030 | $0.00 | 6,030.0000 | 0 | 9999.99% | 0.00% |
| Jan. 3, 2024 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Director | A | Stock Option (right to buy) | 16510 | $0.00 | 16,510.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2023 | Design Therapeutics, Inc. | $DSGN | Schmid John P. | Director | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Director | A | Restricted Stock Unit | 3900 | $0.00 | 3,900.0000 | 0 | 9999.99% | 0.00% |
| Jan. 6, 2023 | ANAPTYSBIO, INC | $ANAB | Schmid John P. | Director | A | Stock Option (right to buy) | 10600 | $0.00 | 10,600.0000 | 0 | 9999.99% | 0.00% |